Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ACTAVIS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
ACTAVIS
Dec-18
SANOFI INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs7,93916,159-   
Low Rs5,45410,840-   
Sales per share (Unadj.) Rs1,202.83,963.8-  
Earnings per share (Unadj.) Rs269.5-1,276.8-  
Cash flow per share (Unadj.) Rs287.7417.7-  
Dividends per share (Unadj.) Rs570.000-  
Avg Dividend yield %8.50-  
Book value per share (Unadj.) Rs527.016,349.0-  
Shares outstanding (eoy) m23.03332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.63.4 163.5%   
Avg P/E ratio x24.9-10.6 -235.0%  
P/CF ratio (eoy) x23.332.3 72.0%  
Price / Book Value ratio x12.70.8 1,539.1%  
Dividend payout %211.50-   
Avg Mkt Cap Rs m154,2244,489,898 3.4%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m4,0590-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m27,7011,318,372 2.1%  
Other income Rs m73025,212 2.9%   
Total revenues Rs m28,4311,343,584 2.1%   
Gross profit Rs m8,34934,548 24.2%  
Depreciation Rs m419563,576 0.1%   
Interest Rs m1776,078 0.0%   
Profit before tax Rs m8,643-579,893 -1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m2,437-7,349 -33.2%   
Profit after tax Rs m6,206-424,648 -1.5%  
Gross profit margin %30.12.6 1,150.1%  
Effective tax rate %28.21.3 2,224.9%   
Net profit margin %22.4-32.2 -69.6%  
BALANCE SHEET DATA
Current assets Rs m36,121540,727 6.7%   
Current liabilities Rs m27,425478,345 5.7%   
Net working cap to sales %31.44.7 663.4%  
Current ratio x1.31.1 116.5%  
Inventory Days Days11720 595.9%  
Debtors Days Days1766 25.7%  
Net fixed assets Rs m12,148149,232 8.1%   
Share capital Rs m2300-   
"Free" reserves Rs m11,9060-   
Net worth Rs m12,1365,437,670 0.2%   
Long term debt Rs m01,914,801 0.0%   
Total assets Rs m48,2798,500,316 0.6%  
Interest coverage x509.4-6.6 -7,692.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.2 369.9%   
Return on assets %12.9-4.1 -314.3%  
Return on equity %51.1-7.8 -654.8%  
Return on capital %71.4-4.8 -1,474.1%  
Exports to sales %14.10-   
Imports to sales %14.60-   
Net fx Rs m-1330-   
CASH FLOW
From Operations Rs m3,987471,005 0.8%  
From Investments Rs m6,509258,756 2.5%  
From Financial Activity Rs m-15,827-808,385 2.0%  
Net Cashflow Rs m-5,331-78,232 6.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare SANOFI INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: ROOPA INDUSTRIES  LYKA LABS  GUJ.TERC LAB  ORCHID PHARMA  S.S.ORGANICS  



Today's Market

Gift Nifty Up 42 Points | Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today Gift Nifty Up 42 Points | Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today(Pre-Open)

Indian share markets Slipped further as the session progressed and ended the day weak.